Experts See Positive Future For South Korean Biomedicine
This article was originally published in PharmAsia News
Executive Summary
Biomedical experts in South Korea believe the outlook for the future of the biotechnology industry in the country is a positive one. The country currently has only a 4 percent share of the world biomedicine market, which is growing at the rate of 13 percent a year. Seoul National University has been one of five institutions around the world working on sequencing the DNA of the local males and females. South Korea's first biomedicine, an antibiotic, now has a $52.9 billion export contract. (Click here for more